Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 4/20 | 0.56 |
| ▸ | HTR2A | P28223 | 5/20 | 0.41 |
| ▸ | HTR2C | P28335 | 5/20 | 0.41 |
| ▸ | HTR1A | P08908 | 4/20 | 0.41 |
| ▸ | HTR7 | P34969 | 4/20 | 0.41 |
| ▸ | DRD3 | P35462 | 3/20 | 0.41 |
| ▸ | HTR2B | P41595 | 2/20 | 0.41 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 3/20 | 0.39 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.38 |
| ▸ | S100A4 | P26447 | 2/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3270736 | 0.80 | METAP1 (0.46) | METAP1HTR2AHTR2CHTR1AHTR7 | |
| SCHEMBL29404958 | 0.77 | METAP1 (0.56) | METAP1HTR2AHTR2CHTR1AHTR7 | |
| SCHEMBL6248819 | 0.77 | METAP1 (0.56) | METAP1HTR2AHTR2CHTR1AHTR7 | |
| SCHEMBL7147610 | 0.77 | ACHE (0.60) | METAP1ACHE | |
| SCHEMBL7590593 | 0.75 | METAP1 (0.54) | METAP1HTR2AHTR2CHTR1AHTR7 | |
| SCHEMBL27317325 | 0.74 | METAP1 (0.53) | METAP1HTR2AHTR2CHTR1AHTR7 | |
| SCHEMBL27346204 | 0.74 | METAP1 (0.53) | METAP1HTR2AHTR2CHTR1AHTR7 | |
| SCHEMBL11563001 | 0.74 | METAP1 (0.53) | METAP1HTR2AHTR2CHTR1AHTR7 | |
| SCHEMBL30666697 | 0.74 | METAP1 (0.53) | METAP1HTR2AHTR2CHTR1AHTR7 | |
| SCHEMBL31208446 | 0.74 | METAP1 (0.53) | METAP1HTR2AHTR2CHTR1AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1425000-B1 | USE OF POLYSUBSTITUTED INDAN-1-OL SYSTEMS FOR PRODUCING DRUGS USED IN THE PROPHYLAXIS OR TREATMENT OF OBESITY | SANOFI AVENTIS DEUTSCHLAND (DE) | 2012-08-01 | — | — | EP | disclosed |
| EP-1423358-B1 | POLYSUBSTITUTED INDAN-1-OL SYSTEMS, METHOD FOR THE PRODUCTION AND USE THEREOF AS DRUGS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-08-04 | — | — | EP | disclosed |
| US-7763662-B2 | Use of C2-substituted indan-1-ol systems for preparing medicaments for the prophylaxis or treatment of obesity | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2010-07-27 | — | — | US | disclosed |
| EP-1423359-B1 | C2-DISUBSTITUTED INDANE-1-ONES AND THEIR DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-07-14 | — | — | EP | disclosed |
| EP-1425267-B1 | C2-SUBSTITUTED INDANE-1-ONES AND THEIR DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-06-30 | — | — | EP | disclosed |
| EP-1425266-B1 | C2-SUBSTITUTED INDANE-1-OLS AND THEIR DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-04-22 | — | — | EP | disclosed |
| EP-1425264-B1 | C2-DISUBSTITUTED INDANE-1-OL SYSTEMS AND THEIR USE AS MEDICAMENTS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2008-10-29 | — | — | EP | disclosed |
| EP-1425265-B1 | DERIVATIVES OF C2-SUBSTITUTED INDAN-1-OL SYSTEMS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2008-10-22 | — | — | EP | disclosed |
| EP-1424985-B1 | USE OF DERIVATIVES OF C2-SUBSTITUTED INDANE-1-OL SYSTEMS FOR PRODUCING MEDICAMENTS FOR THE PROPHYLAXIS OR THE TREATMENT OF OBESITY | SANOFI AVENTIS DEUTSCHLAND (DE) | 2008-02-13 | — | — | EP | disclosed |
| US-7081467-B2 | C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-07-25 | — | — | US | disclosed |
| WO-2003020697-A1 | C2-DISUBSTITUTED INDANE-1-ONES AND THEIR DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020677-A2 | C2-SUBSTITUTED INDANE-1-ONES AND THEIR DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020255-A1 | USE OF POLYSUBSTITUTED INDAN-1-OL SYSTEMS FOR PRODUCING DRUGS USED IN THE PROPHYLAXIS OR TREATMENT OF OBESITY | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020695-A1 | C2-DISUBSTITUTED INDANE-1-OL SYSTEMS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020696-A1 | C2-SUBSTITUTED INDANE-1-OLS AND THEIR DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020694-A1 | DERIVATIVES OF C2-SUBSTITUTED INDAN-1-OL SYSTEMS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020199-A1 | USE OF DERIVATIVES OF C2-SUBSTITUTED INDAN-1-OL SYSTEMS FOR PRODUCING MEDICAMENTS FOR THE PROPHYLAXIS OR THE TREATMENT OF OBESITY | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020256-A1 | USE OF C2-SUBSTITUTED INDANE-1-ONE SYSTEMS FOR PRODUCING MEDICAMENTS FOR THE PROPHYLAXIS OR TREATMENT OF OBESITY | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020263-A1 | USE OF C2-SUBSTITUTED INDANE-1-OL SYSTEMS FOR PRODUCING MEDICAMENTS FOR THE PROPHYLAXIS OR TREATMENT OF OBESITY | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020693-A1 | POLYSUBSTITUTED INDAN-1-OL SYSTEMS, METHOD FOR THE PRODUCTION AND USE THEREOF AS DRUGS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |